Stock Price & Analysis

Based on the analysis of recent upgrades, price target adjustments, and market sentiment, CLMT stock is currently trading near its support levels with mixed analyst opinions. While some analysts see potential upside due to oversold conditions, others remain cautious about earnings risks and cash flow challenges.

Given the stock's 45% decline year-to-date and its current price near Fibonacci support levels, it may be prudent to hold or wait for further market stabilization before making a decision.

Analysts are divided, with UBS upgrading to Neutral and Goldman Sachs maintaining a Buy rating, but both firms have lowered their price targets recently.

The stock's technical indicators, such as RSI and MACD, suggest it may be oversold, but the fundamentals remain uncertain due to policy changes and weaker organic free cash flow generation.

Considering these factors, it may be wise to avoid immediate action and monitor for further developments.

The price prediction for CLMT stock in 2025 is $13.50. This forecast is based on technical indicators showing potential bullish signals, with the stock approaching oversold territory and a possible MACD crossover.

The S1 support level for CLMT Stock is $12.15 ,The R1 resistant level for CLMT Stock is $13.41.

As of the end of day on 2025-03-31, the price of CLMT Stock was $12.69.

The target price for CLMT Stock according to analyst rating is 21.20, with the highest price target at 33.00 and the lowest at 12.00. Analysts have a Moderate Buy rating on CLMT Stock overall.

The market cap of CLMT is $1.1B.

Analysis and Insights

CLMT may be overvalued based on its current valuation metrics and market sentiment. Here's a concise analysis:

1. Valuation Metrics:

   • EV/EBITDA: 9.41, higher than industry averages, suggesting potential overvaluation.
   • PS Ratio: 30.58, indicating high expectations for future growth.
   • PB Ratio: 0.44, lower than peers, reflecting undervaluation relative to book value.

2. Market Sentiment:

   • The stock has declined 45% YTD due to tax credit policy changes and earnings risks.
   • Analysts like UBS have upgraded the stock to Neutral, citing better reflection of risks at current prices.

3. Industry Trends:

   • Declining biodiesel production volumes may benefit CLMT by improving RIN prices and reducing competition.

4. Conclusion:
   While CLMT appears overvalued on some metrics, its decline and analyst upgrades suggest it may not be significantly overvalued. However, risks like policy changes and weaker cash flow persist.

Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a range of consumer-facing and industrial markets. In its Specialty Products and Solutions segment, the Company manufactures and markets a variety of solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. Its Montana/Renewables segment consists of two facilities, renewable fuels, and specialty asphalt. At its Montana Renewables facility, it processes a variety of geographically advantaged renewable feedstocks into renewable diesel, sustainable aviation fuel (SAF), renewable hydrogen, and others. At its Montana specialty asphalt facility, it processes Canadian crude oil into conventional gasoline, diesel, and others. In its Performance Brands segment, it blends, packages and markets high performance products through its Royal Purple, Bel-Ray, and TruFuel brands.

Price Prediction for CLMT Stock by 2030

1. Bullish Scenario: CLMT stock could reach $25 by 2030, driven by improved cash flow and strategic adjustments to policy changes.
2. Bearish Scenario: The stock may drop to $10 if earnings risks and tax credit policy challenges persist.
3. Base Case: A mid-range target of $18 is realistic, balancing recovery potential and current risks.

Reasons:

• Current price reflects earnings risks and cash flow challenges.
• Policy changes from Blender's Tax Credit to Production Tax Credit pose a $100M EBITDA headwind.
• Recent analyst upgrades and price target adjustments indicate mixed sentiment.

CLMT has a total of 1580 employees.